Clinical education for primary and secondary care. Keep updated and ease the pain of the annual appraisal process with our flexible learning platform.
London
Joined November 2010
- Tweets6.8K
- Following1K
- Followers1.5K
- Likes377
MIMS Learning retweeted
GPs should not prescribe semaglutide for CVD risk reduction unless formally commissioned and funded to do so, BMA guidance warns.
Full story: gponline.com/semaglutide-pre…
MIMS Learning retweeted
Read my blog for medical training outlet @mimslearning on the potential reduction in waiting for an #endometriosis diagnosis. And not before time! #endotest #endosure mimslearning.co.uk/pages/mim…
MIMS Learning retweeted
Great to be @mimslearning Live speaking on Obesity in an enjoyable panel discussion with @drpatrickholmes and going solo talking about multiple risk factor management and cardio-reno-metabolic care in primary and secondary care 🤓
MIMS Learning retweeted
A once-daily semaglutide 25mg tablet is soon to be available for private prescribing, after becoming the first oral GLP-1 agonist to receive MHRA approval for weight loss
buff.ly/az3rbVJ
MIMS Learning retweeted
GP practices will take action around medicines optimisation and prescribing from 1 June as the profession ramps up pressure on the government over the imposed 2026/27 contract.
Read more on MIMS
buff.ly/T2OGYOw
MIMS Learning retweeted
NAC & @mimslearning offer a CPD course about #aspergillosis for GPs, to support them in managing patients with fungal lung conditions 🫁
#respiratory #GPs #pulmonary #respisbest #ABPA #MedEd #CME #NHS
MIMS Learning retweeted
Happy to have contributed to this important learning module. Delays in presentation remain a big issue for men, thus avoidance of any delays to diagnosis is crucial for men with penile cancer. @TheChristieNHS
Around 20% of men with penile cancer may be misdiagnosed or inappropriately referred, limiting treatment options. Read our new FREE learning module, produced in partnership with Orchid, for more information on symptoms to look for. buff.ly/sNKmk2H
MIMS Learning retweeted
SGLT2 inhibitors and slow-release metformin should be used as first-line therapy for people newly diagnosed with type II diabetes, according to final NICE type II diabetes guidance published today.
Read more on MIMS
buff.ly/lUmaua9
MIMS Learning retweeted
Today is #WorldAspergillosisDay - you can help by sharing this link with any GPs you know
NAC worked with MIMS to produce this CPD course for learning about #aspergillosis to help CPA and #ABPA be diagnosed and treated faster
#respiratory #GPs #pulmonary #respisbest – at Manchester, England
Aspergillus is a mould that is often seen in damp homes, and exposure can lead to #aspergillosis. This module, by specialists from the National Aspergillosis Centre (@MFT_NAC), looks at the diagnosis and management of the condition. buff.ly/rDAuxW9
MIMS Learning retweeted
Podcast: Adopting new tech and AI in general practice
Full episode: gponline.com/podcast-adoptin…
MIMS Learning retweeted
VOTE NOW! We’ve been shortlisted for the LPI #learningawards for our work on targeting health inequalities. Click here to watch our video and vote for your preferred option! Voting closes Friday 16th January, 5pm. @Haymarket_Media buff.ly/VbyQkMP
MIMS Learning retweeted
Have you seen this #CPD module @mimslearning? GP Dr Pipin Singh explores the challenges of supporting people living with obesity in primary care. He looks at support available to patients + outlines management options, including GLP-1 medicines + surgery. mimslearning.co.uk/courses/o…
MIMS Learning retweeted
The #MIMSHealthcareNetwork — which includes MIMS, @mimslearning , @GPonlinenews, and #GPBusiness — is delighted to announce the launch of the #MIMSPharma website, which is dedicated to serving the needs of pharma professionals
For more info, see
mimspharma.co.uk/
MIMS Learning retweeted
This week's news in brief:
▶️ Oral GLP-1 drug elicits significant weight loss in phase III trial
▶️ Obesity care access to be boosted by innovation programme
▶️ Heart failure drug trial enrolls first European patient at UK practice
Read more on MIMS
buff.ly/4p2otGh
MIMS Learning retweeted
📢NEW ONLINE EVENT FOR HEALTHCARE PROFESSIONALS Tues 16 Sept 7 - 8 pm
An opportunity to learn about the new @RCObsGyn Greentop Guideline on the Management of Thyroid Disorders in Pregnancy.
Register free-of-charge tinyurl.com/2f8z4xpa
@mimslearning #thyroid #pregnancy #hcps
ALT Graphic shows some sperm swimming towards an egg. Title reads: Understanding and Managing Fertility and Pregnancy in Thyroid Disease' Words underneath read: MIMS Learning Webinar in association with British Thyroid Foundation
MIMS Learning retweeted
On the road again to end #periodpoverty, this time at a church in #Tameside. More details coming soon. Meanwhile, read more about my work on this growing problem at endometriosisawarenessnorth.…
MIMS Learning retweeted
Two new annual reports from MIMS offer exclusive insights into current prescribing practice for women's health conditions and diabetes and obesity.
Read more on MIMS
buff.ly/OLfwhfS
MIMS Learning retweeted
A single national medicine formulary will replace local formularies, with the goal of ending the postcode lottery of drug access, the government has revealed in its new 10-year plan for the NHS.
Read more on MIMS
buff.ly/z42p0jQ
MIMS Learning retweeted
Did you know MIMS publishes, and regularly updates, live product trackers to help GPs and other primary care professionals with prescribing decisions?
The trackers include #drugshortages #drugprices and #newproducts.
See more on MIMS
buff.ly/3sRrybZ
MIMS Learning retweeted
Structured medication reviews must be performed in people with complex and problematic pharmacy, pharmacist Laura Buckley reminds prescribers in a new CPD module on MIMS Learning (@MIMSLearning)
Read more on MIMS
buff.ly/w7uLjgf